IBIO
iBio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.31
+0.77%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3369.70x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.98x
- Price / sales
- 842.43x
- Price / cash flow
- -3.63x
Enterprise value
- Enterprise value
- $30.0M
- EV / sales
- 300.46x
- EV / EBITDA
- -0.93x
- EV / EBIT
- -0.85x
- Market cap
- $84.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026